CRS: JHU
Position: Co-investigator
CRS: BJMC
Position: Dean, BJ Medical College and India CRS PI
Position: Study Coordinator
Position: CRS Leader
Position: CTU Leader for HPTN Studies
Position: Site Leader
Position: Global Community Advisory Board Representative
CRS: BJMCJHU
Position: Principal Investigator, Johns Hopkins Professor of Medicine and Public Health; Deputy Director, CCGHE
Position: CRS Data Manager and Deputy Director
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...